| 2026-03-25 |
详情>>
股本变动：
变动后总股本5995.83万股
|
| 2026-03-25 |
详情>>
业绩披露：
2025年年报每股收益0.02美元,归母净利润127.88万美元,同比去年增长90.74%
|
| 2026-03-25 |
财报披露：
美东时间 2026-03-25 盘后发布财报
|
| 2026-01-06 |
详情>>
内部人交易：
Qian LinLin等共交易3笔
|
| 2025-11-12 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.03美元,归母净利润158.14万美元,同比去年增长94.13%
|
| 2025-09-08 |
股东大会：
将于2025-10-03召开股东大会
会议内容 ▼▲
- 1.To elect five persons to our board of directors (the “Board of Directors”), to serve until the annual meeting of stockholders to be held in 2026 and until their respective successors are elected and qualified, or until their earlier death, resignation, disqualification, or removal (“Proposal One”);
2.To amend the Company’s Health in Tech Equity Incentive Plan (2024) to (i) increase the total number of shares of Class A common stock authorized for issuance pursuant to awards granted thereunder from 7,677,849 shares to 10,677,849 shares and (ii) to include the issuance of up to 2,000,000 shares of Class B common stock, and options convertible into Class B common stock to executive officers of the Company (“Proposal Two”);
3.To ratify the appointment of MaloneBailey, LLP as the Company’s independent auditors for the year ending December 31, 2025 (“Proposal Three”);
4.To transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.
|
| 2025-08-08 |
详情>>
业绩披露：
2025年中报每股收益0.02美元,归母净利润112.92万美元,同比去年增长157.49%
|
| 2025-05-14 |
复牌提示：
2025-05-14 11:35:09 停牌，复牌日期 2025-05-14 11:40:09
|
| 2025-05-09 |
详情>>
业绩披露：
2025年一季报每股收益0.01美元,归母净利润49.86万美元,同比去年增长395.93%
|
| 2025-03-17 |
详情>>
业绩披露：
2024年年报每股收益0.01美元,归母净利润67.05万美元,同比去年增长-72.93%
|
| 2024-11-06 |
详情>>
业绩披露：
2023年年报每股收益0.08美元,归母净利润247.67万美元,同比去年增长3005.84%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.02美元,归母净利润81.46万美元,同比去年增长-44.75%
|
| 2024-08-30 |
详情>>
业绩披露：
2024年中报每股收益0.01美元,归母净利润43.85万美元,同比去年增长-59.09%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|